The Priority Review

Tag

Pentaxim

1 story

Stories

  1. Clinical trials

    Sanofi registers Phase 3 study of Hexaxim versus Pentaxim in Chinese infants

    The study, first posted on ClinicalTrials.gov on November 17, 2026, plans to enroll 720 healthy Chinese infants to compare the safety and immunogenicity of Hexaxim with Pentaxim plus a monovalent Hep B vaccine. It plans to start on December 28, 2026, with primary completion by April 27, 2028.